Guanidine degradation enzyme and methods of use
AssigneesAlliance for Sustainable Energy, LLC, Vanderbilt University
InventorsJianping Yu, Bo Wang
Life of this patent
Estimating the term…
Abstract
Presented herein are Synechococcus strains engineered to express the bacterial ethylene-forming enzyme (EFE) that exhibit unstable ethylene production due to toxicity and genomic instability induced by accumulation of the EFE-byproduct guanidine. Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production. The engineered strains and methods disclosed herein are useful for guanidine degradation pathways and for ethylene bioproduction in cyanobacteria.
Claims7
A non-naturally occurring Synechocystis or Synechococcus cyanobacterial strain engineered to express a heterologous bacterial ethylene-forming enzyme (EFE) and a guanidine degradation enzyme.
Dependencies are inferred from the claim text.